A hemoglobin based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus hetastarch (HEX) in an uncontrolled liver injury hemorrhagic shock swine model with delayed evacuation

被引:42
|
作者
Gurney, J
Philbin, N
Rice, J
Arnaud, F
Dong, F
Wulster-Radcliffe, M
Pearce, LB
Kaplan, L
McCarron, R
Freilich, D
机构
[1] USN, Med Res Ctr, Silver Spring, MD 20910 USA
[2] Walter Reed Army Med Ctr, Washington, DC 20307 USA
[3] Purdue Univ, W Lafayette, IN 47907 USA
[4] Biopure Corp, Cambridge, MA USA
[5] Yale Univ, Sch Med, New Haven, CT USA
关键词
combat casualty; hemorrhagic shock; swine; HBOC-201; hextend; liver injury; uncontrolled hemorrhage;
D O I
10.1097/01.TA.0000147520.84792.B4
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: As HBOC-201 improves outcome in animals with hemorrhagic shock (HS), we compared HBOC-201 and HEX (used by U.S. military special operations forces) in a swine model of delayed evacuation and uncontrolled HS. Methods: Twenty-four Yucatan pigs underwent a grade HI liver injury and were resuscitated with HBOC-201, HEX, or no fluid (NON). Additional infusions were given for hypotension or tachycardia. After 4 hours, the liver was repaired; IV fluids and blood transfusions were administered. Pigs were monitored for 72 hours. Results: Survival was 7/8, 1/8, and 1/8 in HBOC-201-, HEX-, and NON-resuscitated pigs, respectively. Compared with HEX, HBOC-201 pigs had higher systemic and pulmonary artery pressures and had comparable cardiac outputs, but were less tachycardic. Transcutaneous tissue oxygenation was restored more rapidly in HBOC-201 pigs, there was a trend to lower lactic acid, and base deficit was less. HBOC-201 pigs had lower fluid requirements, higher urine output, and lower blood loss than HEX pigs. Conclusions: Despite evidence of vasoactivity, HBOC-201 more effectively stabilized tissue oxygenation, reversed anaerobic metabolism, decreased bleeding, and increased survival in comparison with HEX. If confirmed in clinical trials, these data suggest that for the resuscitation of combat casualties with delayed evacuation and uncontrolled HS due to solid organ injury, HBOC-201 is a superior low-volume resuscitative fluid.
引用
收藏
页码:726 / 738
页数:13
相关论文
共 50 条
  • [31] Freeze-dried plasma mitigates the dilution effects of a hemoglobin-based oxygen carrier (HBOC-201) in a model of resuscitation for hemorrhage and hemodilution
    Meledeo, Michael Adam
    Peltier, Grantham C.
    McIntosh, Colby S.
    Taylor, Ashley S.
    Bynum, James A.
    Pusateri, Anthony E.
    Cap, Andrew P.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2019, 87 : S83 - S90
  • [32] Innate immune response after resuscitation with hemoglobin-based oxygen carrier and recombinant factor VIIA in uncontrolled hemorrhagic shock in a swine model
    Malkevich, Nina V.
    Dong, Feng
    VanderMolen, Christine A.
    Philbin, Nora B.
    Rice, Jennifer P.
    Scultetus, Anke
    Hong, Jiang
    Arnaud, Francoise
    Hall, Carrie H.
    McGwin, Gerald, Jr.
    Pearce, L. Bruce
    Handrigan, M.
    Ahlers, Stephen
    McCarron, Richard M.
    Freilich, Daniel
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2008, 64 (06): : 1498 - 1510
  • [33] A hemoglobin based oxygen carrier (HBOC-201) has similar effects to conventional resuscitation fluids on cytokine responses in an acute trauma-hemorrhage model
    Hutchings, Anne
    Rodriguez, Celina
    George, Richard
    Moon-Massat, Paula
    Rue, Loring, III
    Kerby, Jeffrey
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [34] Preoxygenated hemoglobin-based oxygen carrier HBOC-201 annihilates myocardial ischemia during brief coronary artery occlusion in pigs
    Hekkert, Maaike Te Lintel
    Dube, Gregory P.
    Regar, Evelyn
    de Boer, Martine
    Vranckx, Pascal
    van der Giessen, Wim J.
    Serruys, Patrick W.
    Duncker, Dirk J.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 298 (03): : H1103 - H1113
  • [35] Low-volume resuscitation with a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) provides adequate tissue oxygenation for survival in a porcine model of controlled hemorrhage
    York, GB
    Eggers, JS
    Smith, DL
    Jenkins, DH
    McNeil, JD
    Mueller, D
    Josephs, JD
    Kerby, JD
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2003, 55 (05): : 873 - 885
  • [36] Effects of a hemoglobin-based oxygen carrier (HBOC-201) and derivatives with altered oxygen affinity and viscosity on systemic and microcirculatory variables in a top-load rat model
    Song, Bjorn Kyungsuck
    Nugent, William H.
    Moon-Massat, Paula F.
    Pittman, Roland N.
    MICROVASCULAR RESEARCH, 2014, 95 : 124 - 130
  • [37] Immune effects of decreasing low-molecular weight hemoglobin components of hemoglobin-based oxygen carriers (HBOC) in a swine model of severe controlled hemorrhagic shock
    VanderMolen, C.
    Malkevich, N.
    Philbin, N.
    Rice, J.
    Collier, S.
    Hall, C.
    Ahlers, S.
    McCarron, R.
    Freilich, D.
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2007, 35 (05): : 507 - 517
  • [38] Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery
    Kasper, SM
    Walter, M
    Grune, F
    Bischoff, A
    Erasmi, H
    Buzello, W
    ANESTHESIA AND ANALGESIA, 1996, 83 (05): : 921 - 927
  • [39] The use of hemoglobin-based oxygen carrying solution (HBOC-201) for extracorporeal membrane oxygenation (ECMO) in a pig model with ARDS
    Henderson, CL
    Anderson, CM
    Sorrells, DL
    Dick, EJ
    DiGeronimo, RJ
    PEDIATRIC RESEARCH, 2003, 53 (04) : 45A - 45A
  • [40] Innate immune responses in swine resuscitated from severe traumatic hemorrhagic shock with hemoglobin-based oxygen carrier-201
    Hall, C.
    Malkevich, N.
    Handrigan, M.
    VanderMolen, C.
    Aranaud, F.
    Hong, J.
    Dong, F.
    Rice, J.
    Philbin, N.
    Ahlers, S.
    McCarron, R.
    Freilich, D.
    McGwin, G.
    Flournoy, W. S.
    Pearce, L. Bruce
    ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY, 2007, 35 (03): : 259 - 274